Onderneming VBI Vaccines Inc. Toronto S.E.
Aandelen
VBV
CA91822J1030
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,82 CAD | -5,12% | -7,66% | -10,58% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
License
41,4
%
| - | - | 4 | 41,4 % | - |
Vaccines
35,8
%
| 1 | 86,0 % | 3 | 35,8 % | +233,73% |
Research & Development Service
22,8
%
| 0 | 14,0 % | 2 | 22,8 % | +1.210,60% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China/Hong Kong
64,3
%
| 0 | 6,1 % | 6 | 64,3 % | +8.362,12% |
United States
21,3
%
| 1 | 64,2 % | 2 | 21,3 % | +165,47% |
Europe
12,5
%
| 0 | 0,6 % | 1 | 12,5 % | +17.983,33% |
Israel
1,9
%
| 0 | 29,1 % | 0 | 1,9 % | -46,98% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01-05-16 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 09-07-15 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 06-05-16 |
Chief Tech/Sci/R&D Officer | 69 | 01-02-16 | |
Nicole Anderson
IRC | Investor Relations Contact | - | 01-10-17 |
Corporate Officer/Principal | 59 | 23-05-17 | |
Misha Nossov
PRN | Corporate Officer/Principal | - | 01-05-10 |
John Dillman
PRN | Corporate Officer/Principal | 56 | 12-07-22 |
Avi Mazaltov
PRN | Corporate Officer/Principal | 62 | 30-03-17 |
T. Buckley
PRN | Corporate Officer/Principal | 48 | 01-01-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 24-04-23 |
Steven Gillis
CHM | Chairman | 71 | 01-01-05 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01-05-16 |
Damian Braga
BRD | Director/Board Member | 68 | 09-03-20 |
Michel de Wilde
BRD | Director/Board Member | 74 | 01-05-16 |
Blaine McKee
BRD | Director/Board Member | 59 | 11-01-19 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 09-07-15 |
Joanne Cordeiro
BRD | Director/Board Member | 66 | 15-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 682 275 | 25 243 110 ( 88,01 %) | 0 | 88,01 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,37% | 44,96 mld. | |
-1,01% | 42,65 mld. | |
+46,00% | 41,85 mld. | |
-5,31% | 29,04 mld. | |
+9,34% | 26,08 mld. | |
-21,69% | 19,03 mld. | |
+6,23% | 12,75 mld. | |
+26,99% | 12,06 mld. | |
-3,38% | 11,75 mld. |
- Beurs
- Aandelen
- Koers VBIV
- Koers VBV
- Onderneming VBI Vaccines Inc.